2020 Impact of COVID

Impact of COVID-19: findings from a GLCC members survey

Patient advocacy and support organisations like the members of the GLCC engage with thousands of patients worldwide. Our members are working hard to support lung cancer patients through the COVID-19 pandemic and, in some cases, doing this with decreased resources. It is essential that policymakers recognise the critical role that patient organisations play in supporting patients every day, but particularly in difficult times like these.

In May 2020, a survey was sent out asking our members about their experiences through the pandemic. Questions were based on four themes: demand, need, services, and finance. 22 organisations from 21 countries and one Europe-wide organisation responded: Argentina, Australia, Bulgaria, Canada, Czech Republic, Denmark, Germany, Ireland, Israel, Italy, Mexico, the Netherlands, Peru, Portugal, Slovenia, South Africa, Spain, Sweden, Taiwan, the UK, and the USA.

The headline findings from the survey can be found HERE and can be downloaded as a Word doc. There were 23 responses to the survey overall, but not every organisation answered each question

RESEARCH - The State of Global Lung Cancer Research - 2020 data now published / NEWS - global COVID-19 updates